Wah Yuet-B (02256) rose more than 7%, as of publication, up 7.58%, at HKD 2.98, with a turnover of HKD 6.2696 million.
According to the Wisdom Wealth APP, Wah Yuet-B (02256) rose more than 7%, up 7.58% as of publication, at HKD 2.98, with a turnover of HKD 6.2696 million.
In terms of company news, Wah Yuet recently announced its mid-term performance, with revenue of CNY 0.497 billion, a year-on-year increase of 2509%, mainly due to the upfront payment from Merck. R&D expenses were CNY 0.215 billion, up 5.1% year-on-year, mainly due to the advancement of the company's pipeline project. The profit was CNY 0.207 billion, and the operating cash flow was positive.
In addition, Wah Yuet values shareholder returns and has implemented a repurchase program to demonstrate its confidence in development. Since March of this year, the company has continued to implement the repurchase plan. As of June 30, the company has accumulated a repurchase of 18.571 million shares, with a total repurchase amount of HKD 56.3188 million. According to the share buyback plan disclosed by Wah Yuet on July 4, the company has repurchased a total of 15.833 million shares at a repurchase price of HKD 2.72-3.41 per share, accounting for 2.25% of the total number of publicly issued shares, and all were cancelled on July 3.